Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Cortechs.ai wins FDA clearance for NeuroQuant PET

19 August 2026 · By · Wire by Fusion42

Published

19 August 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at auntminnie.com →

◆ Verified

Fusion42 · 19 August 2026 · Fusion42 review

Cortechs.ai has received FDA clearance for its NeuroQuant PET software, a tool designed to assist in the quantification and analysis of PET brain scans for neurological conditions.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

Your health AI product now faces stiffer competition as NeuroQuant PET gains FDA clearance, signalling a growing acceptance of AI tools in brain imaging. Prepare to accelerate regulatory filings or partnerships to keep pace in clinical markets.

◆ Coverage

1 source · 19 Aug 2026

◆ Related on Wire

◆ Topics

Digital Healthfda-clearancemedical-imagingai-healthtechpet-scansneurology